Ilan Ganot - 01 Oct 2026 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director
Issuer ticker: SLDB
Reported as of: 01 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Oct 2026, 16:05:03 UTC
Prior SEC filing: 11 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot

Filing notes and source

Key filing fact

Ilan Ganot filed Form 4 for Solid Biosciences Inc. (SLDB) on 26 Oct 2026.

Key facts

This page summarizes Ilan Ganot's Form 4 filing for Solid Biosciences Inc. (SLDB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 26 Oct 2026, 16:05.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001727460 Primary reporting owner

Relationship: Director
Address: C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN
Signature: /s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot
Signature date: 26 Oct 2026

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

Footnote F2

The RSUs were granted on October 1, 2026 and vest in full on October 1, 2029, subject to Ms. Ganot's continued service through the vesting date.